Enterprise Value
80.71M
Cash
288.6M
Avg Qtr Burn
-23.67M
Short % of Float
5.52%
Insider Ownership
14.72%
Institutional Own.
96.51%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|